Professionals 249 Users Online

Circadian Rhythm Sleep Treatment Market

Global Market Study on Circadian Rhythm Sleep Treatment: Extensive research in therapy devices along with adoption of drugs to drive the growth

Circadian Rhythm Sleep Treatment Market Segmented By Delayed Sleep Phase Syndrome, Advanced Sleep Phase Syndrome, Non–24-h sleep-wake syndrome, Irregular Sleep-Wake Disorder, Shift Work Disorder Disorder

Circadian Rhythm Sleep Treatment Market Outlook (2022 - 2026)

Circadian Rhythm Sleep Treatment Market witnessed a CAGR of 4.6% between 2013 and 2021. The global Circadian Rhythm Sleep Treatment Market is expected to witness a 4.7%CAGR between 2022 and 2026. In 2022, the global Circadian Rhythm Sleep Treatment Market size was US$ 714.7 million, which is projected to reach US$ 857.8 million by the year 2026.

Attribute Key Insights

Cardiac Marker Analyzer Market Size (2022)

US$ 714.7 Mn

Projected Market Value (2026)

US$ 857.8 Mn

Global Market Growth Rate (2022-2026)

4.7%CAGR

Share in parent market

23.1

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Circadian Rhythm Sleep Treatment Market Demand Analysis (2013-2021) v/s Market Outlook (2022-2026)

Circadian Rhythm Sleep Treatment Market is expected to witness at a CAGR of 4.7% during the forecast period between 2022 and 2026. The rise in sleep disorders and rapidly changing lifestyle are contributing to the increasing demand for Circadian Rhythm Sleep Treatments. Furthermore, product development in therapeutic devices and drug adoption for circadian rhythm sleep treatment is expected to drive the global Circadian Rhythm Sleep Treatment Market.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What is expected to keep the Hopes High for Circadian Rhythm Sleep Treatment Market?

  • An increase in the number of sleep disorders

The need for proper sleep treatment has increased due to the growing prevalence of sleep disorders such as Delayed Sleep Phase Syndrome, Advanced Sleep Phase Syndrome, Non–24-h sleep-wake syndrome, and others, is contributing to significant growth in the Circadian Rhythm Sleep Treatment Market growth globally. Furthermore, product development in therapy devices and adoption of drugs for circadian rhythm sleep treatment are the factors expected to boost the circadian rhythm sleep treatment market.

circadian-rhythm-sleep-treatment-market

  • Increased risk of fatal accidents due to a disrupted sleep pattern

Accidents and human mishaps are commonly related to sleep issues. The number of people killed in car accidents is expected to double to 2.3 million globally, with 230,000–345,000 deaths caused by exhaustion or drowsiness. Similarly, disrupted sleep is projected to increase the chance of a deadly workplace accident. As a result of the increased risk of fatal accidents caused by disrupted sleep, the treatment rate rises, driving the worldwide circadian rhythm sleep treatment market forward.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

What restraints is the Circadian Rhythm Sleep Treatment Market subject to?

  • “Lack of awareness”

The lack of awareness about the key concerns associated with circadian rhythm sleep disorders among people in underdeveloped nations may stifle the expansion of the circadian rhythm sleep treatment market. Furthermore, carelessness towards drug side effects and sleep problems might impede the growth of the circadian rhythm sleep treatment market.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

How has Covid-19 affected the Circadian Rhythm Sleep Treatment Market?

“Decrease in demand due to lockdown”

The COVID-19 pandemic had a negative impact on the global economy, and it had a significant impact on the Circadian Rhythm Sleep Treatment Market. Due to strict lockdown, doctors shifted to tele-medicine as the hospitals were flooded with virus patients. Apart from this due to the stringent lockdown regulations and disruptions in the supply chain activities there was a decrease in the availability and sales of Circadian Rhythm Sleep Treatment devices around the world. However, the global Circadian Rhythm Sleep Treatment industry stabilized after 2021.

Competitive Landscape

The Circadian Rhythm Sleep Treatment industry is very competitive and highly consolidated due to the presence of several large players. Key players in the market are focusing on mergers and acquisitions as the industry is in the growth phase. Companies are making strategic decisions to engage in mergers and acquisitions in order to expand their product portfolios and grow their market share.

  • Natus Medical Incorporated, USA has its Embla N7000 system doing the rounds. It is used for performing overnight PSG, i.e. between 10 p.m. and 6 a.m. The supervision happens at the hands of well-experienced sleep physicians as per the AASM manual 2.5.

Along with inorganic modes of expansion, organic modes are also being looked upon as feasible means. Continuous innovation is actually the lifeline of circadian rhythm sleep treatment market and the status quo is expected to remain the same even in the forecast period (2022-2026).

Circadian Rhythm Sleep Treatment Industry Report Scope

Attribute Details

Forecast Period

2022-2026

Historical Data Available for

2013-2021

Market Analysis

US$ Mn/Bn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • India
  • China
  • Japan
  • UAE
  • Australia

Key Market Segments Covered

By Disorder

Key Companies Profiled

  • Natus Medical Incorporated
  • Compumedics Ltd. -
  • Teva Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Company
  • Koninklijke Philips N.V
  • Mylan N.V
  • Fitbit, Inc
  • Garmin Ltd
  • Lucimed S.A.
  • RedMed Inc.
  • Compass Health Brands (Carex Health)
  • Beurer GmbH
  • Samarit Medical AG
  • Lanaform N.V.
  • Others.

Customization & Pricing

Available upon Request

Circadian Rhythm Sleep Treatment Market Categorization

Circadian Rhythm Sleep Treatment Market by Disorder

  • Delayed Sleep Phase Syndrome
  • Advanced Sleep Phase Syndrome
  • Non–24-h sleep-wake syndrome
  • Irregular Sleep-Wake Disorder
  • Shift Work Disorder
  • Jet Lag

Circadian Rhythm Sleep Treatment Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

- Companies Covered in This Report -

  • Vanda Pharmaceuticals Inc.
  • Natus Medical Incorporated
  • Compumedics Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Company
  • Koninklijke Philips N.V
  • Mylan N.V
  • Fitbit, Inc
  • Garmin Ltd
  • Lucimed S.A.
  • RedMed Inc.
  • Compass Health Brands (Carex Health)
  • Beurer GmbH
  • Samarit Medical AG
  • Lanaform N.V.

- Frequently Asked Questions -

In 2022, the Circadian Rhythm Sleep Treatment Market stands at USD 717.4 million, and it is expected to reach USD 857.8 million by 2026 at a CAGR of 4.7%.

Circadian Rhythm Sleep Treatment Market exhibited a 4.6% CAGR between 2013 and 2021.

The lack of awareness about the key concerns associated with circadian rhythm sleep disorders among people is the key restraint in the Cardiac Marker Analyzer Market.

An increase in the number of sleep disorders and rapid change in the lifestyles are the key factors driving the growth of the market.

Natus Medical Incorporated, Compumedics Ltd., Teva Pharmaceutical Industries Ltd, and Takeda Pharmaceutical Company are among the top players in the market.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate